ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

Research output: Contribution to journalArticlepeer-review


Colleges, School and Institutes

External organisations

  • Cardiff University
  • Velindre Cancer Centre


Original languageEnglish
Pages (from-to)4101-410
Number of pages9
JournalJournal of Clinical Oncology
Publication statusPublished - 2020